• International Journal of Contents
• /
• v.2 no.1
• /
• pp.5-8
• /
• 2006

This paper describes a new mechanism of detecting object of interest from a noisy image, without using any a-priori knowledge about the target. It employs a parallel set of filters inspired upon biological findings of mammalian vision. In our proposed system, several basic features are extracted directly from original input visual stimuli, and these features are integrated based on their local competitive relations and statistical information. Through integration process, unnecessary features for detecting the target are spontaneously decreased, while useful features are enhanced. Experiments have been performed on a set of computer generated and real images corrupted with noise.

• Proceedings of the Korean Society of Precision Engineering Conference
• /
• 2012.05a
• /
• pp.497-498
• /
• 2012

• Journal of Animal Reproduction and Biotechnology
• /
• v.38 no.1
• /
• pp.2-9
• /
• 2023

Mammalian eyes have a limited ability to regenerate once neurons degenerate. This results in visual impairment that impacts the quality of life among adult populations as well as in young children leading to lifelong consequences. Various therapies are in development to restore vision, and these include gene therapy, stem cell therapy, in-vivo transdifferentiation, and transplantation of a patient's whole eye obtained from interspecies blastocyst complementation. This review discusses advances in the research as well as hurdles that need to be resolved to have a successful restoration of vision.

• Journal of Life Science
• /
• v.21 no.11
• /
• pp.1652-1657
• /
• 2011

The production of blood cells is regulated by more than 20 different growth factors, called hematopoitic growth factors. These factors have been produced in prokaryotic and mammalian systems for their clinical use. Glranulocyte-Colony Stimulating Factor (G-CSF) is an important therapeutic factor for cancer patients as well as patients with congenital conditions. These patients do not have enough neutrophils and have a high risk of infection. Two groups of recombinant G-CSF have been used to specially treat cancer patients after chemotherapy because chemotherapy induces neutropenia, a major side effect of chemotherapy drugs. Here, structural and biological characteristics of G-CSF are presented. In addition, the relationship between chemotherapy and neutropenia, which is a severe reduction of neutrophils in the blood, and clinical application of G-CSF is discussed. Recombinant G-CSFs are grouped in two forms. Non-glycosylated G-CSF, filgrastim, is produced in Escherichia coli and glycosylated G-CSF, lenograstim, is produced in Chinese hamster ovary cells. Differences in structure and biological activity are compared and challenges for biosimilar production are also highlighted.